Rasburicase is a newer drug used in gout. It act by:
**Core Concept**
Rasburicase is a recombinant enzyme that acts as an urate oxidase, involved in the breakdown of uric acid in the body. This enzyme catalyzes the oxidation of uric acid to 5-hydroxyisourate, which is further broken down into allantoin, a more soluble compound that can be easily excreted.
**Why the Correct Answer is Right**
Rasburicase works by catalyzing the oxidation of uric acid, thereby reducing its levels in the blood and tissues. This action is particularly beneficial in the treatment of tumor lysis syndrome, where high levels of uric acid can cause kidney damage. The enzyme acts by breaking down uric acid into 5-hydroxyisourate, which is then further metabolized to allantoin, a compound that is more soluble and can be easily excreted by the kidneys.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as rasburicase does not act by inhibiting xanthine oxidase, which is the enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid.
**Option B:** This option is incorrect as rasburicase does not act by increasing the excretion of uric acid in the urine. While it does reduce uric acid levels by breaking it down, it does not directly increase its excretion.
**Option C:** This option is incorrect as rasburicase does not act by activating the uricosuric pathway, which is responsible for increasing the excretion of uric acid in the urine. Rasburicase works by breaking down uric acid, rather than increasing its excretion.
**Clinical Pearl / High-Yield Fact**
Rasburicase is particularly useful in the treatment of tumor lysis syndrome, where rapid reduction of uric acid levels is critical to prevent kidney damage. It is also effective in reducing uric acid levels in patients with severe gout, when other treatments have failed.
**Correct Answer:** C.